Australia markets closed

Cue Biopharma, Inc. (CUE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3700-0.0400 (-2.84%)
As of 02:51PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-50,733
-50,733
-53,010
-44,161
-44,785
Depreciation & amortisation
3,436
3,436
1,806
-1,778
-3,145
Stock-based compensation
8,180
8,180
9,496
11,516
10,481
Change in working capital
-934
-934
356
-4,387
5,435
Accounts receivable
-1,641
-1,641
3,085
-1,725
-662.584
Accounts payable
770
770
83
520.398
741.265
Other working capital
-39,961
-39,961
-41,977
-39,750
-33,089
Other non-cash items
37
37
-246
-
-563.232
Net cash provided by operating activities
-39,961
-39,961
-41,806
-38,837
-32,494
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-171
-913.039
-595.259
Purchases of investments
0
0
-29,445
0
-9,949
Sales/maturities of investments
25,000
25,000
5,000
10,000
15,000
Net cash used for investing activities
25,002
25,002
-24,610
9,109
4,456
Cash flows from financing activities
Debt repayment
-2,000
-2,000
0
-
-
Common stock issued
13,387
13,387
39,300
17,385
56,682
Other financing activities
-
-
-341
-750.128
-271.051
Net cash used provided by (used for) financing activities
11,860
11,860
53,659
19,233
58,614
Net change in cash
-3,099
-3,099
-12,757
-10,495
30,576
Cash at beginning of period
51,764
51,764
64,521
75,016
44,440
Cash at end of period
48,665
48,665
51,764
64,521
75,016
Free cash flow
Operating cash flow
-39,961
-39,961
-41,806
-38,837
-32,494
Capital expenditure
-
-
-171
-913.039
-595.259
Free cash flow
-39,961
-39,961
-41,977
-39,750
-33,089